RGNX   $11.1  4.72% Market Closed After Close 11.1 0.0

Regenxbio Inc
Total Cash 290.36M
totalCashPerShare 5.875
EBITDA -226.02M
Total Debt 158.72M
quickRatio 3.414
currentRatio 3.528
Total Revenue 89.04M
debtToEquity 45.573
Revenue/Share 1.933
ROA -0.24261
ROE -0.63936
grossProfits
freeCashflow -105.63M
operatingCashflow -191.12M
earningsGrowth
revenueGrowth 0.116
grossMargins -1.98511
ebitdaMargins -2.53834
operatingMargins -2.51343
profitMargins -2.70738
enterpriseValue 377.42M
forwardPE -6.321839
floatShares 40.80M
sharesOutstanding 49.42M
sharesShort 5.31M
sharesShortPriorMonth 6.07M
dateShortInterest
sharesPercentSharesOut 0.11%
heldPercentInsiders 0.07%
heldPercentInstitutions 0.92%
Short Ratio help_outline 9.58%
shortPercentOfFloat 0.14%
impliedSharesOutstanding
bookValue 7.062
Price To Book help_outline 1.56
earningsQuarterlyGrowth
netIncomeToCommon -241.08M
trailingEps -5.24%
forwardEps -1.74%
enterpriseToEbitda -1.67
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.12 3Q 2024
institutionsCount 266
lastUpdated Oct. 16, 2024, 6:19 p.m.